ID: ALA395723

Max Phase: Preclinical

Molecular Formula: C43H60N8O10

Molecular Weight: 849.00

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C

Standard InChI:  InChI=1S/C43H60N8O10/c1-22(2)18-30(44)38(55)46-24(5)37(54)49-35(23(3)4)41(58)48-33(19-26-13-15-28(53)16-14-26)42(59)51-17-9-12-34(51)40(57)47-32(39(56)50-36(25(6)52)43(60)61)20-27-21-45-31-11-8-7-10-29(27)31/h7-8,10-11,13-16,21-25,30,32-36,45,52-53H,9,12,17-20,44H2,1-6H3,(H,46,55)(H,47,57)(H,48,58)(H,49,54)(H,50,56)(H,60,61)/t24-,25+,30-,32-,33-,34-,35-,36-/m0/s1

Standard InChI Key:  HOZWDBPFSGBJBM-DTSDQQARSA-N

Associated Targets(Human)

P2X purinoceptor 3 1991 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

P2X purinoceptor 7 5534 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P2X purinoceptor 1 68 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 849.00Molecular Weight (Monoisotopic): 848.4432AlogP: 0.59#Rotatable Bonds: 20
Polar Surface Area: 285.38Molecular Species: ACIDHBA: 10HBD: 10
#RO5 Violations: 2HBA (Lipinski): 18HBD (Lipinski): 11#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.68CX Basic pKa: 8.11CX LogP: -1.17CX LogD: -1.24
Aromatic Rings: 3Heavy Atoms: 61QED Weighted: 0.08Np Likeness Score: 0.04

References

1. Jung KY, Moon HD, Lee GE, Lim HH, Park CS, Kim YC..  (2007)  Structure-activity relationship studies of spinorphin as a potent and selective human P2X(3) receptor antagonist.,  50  (18): [PMID:17676725] [10.1021/jm070114m]

Source